A phase I study of JS001, a humanized IgG4 mAb against programmed death-1 (PD-1) in patients with advanced solid tumors.

作者:Zhihong Chi; Bixia Tang; Xinan Sheng; Lu Si; Chuanliang Cui; Yan Kong; Dan Li; Si Ming Li; Xieqiao Yan; Li Li Mao; Bin Lian; Xue Bai; Xuan Wang; Li Zhou; Jiayi Yu; Mingli Xu; Lihou Dong; Haifeng Song; Jun Guo
来源:Journal of Clinical Oncology, 2017, 35(15_suppl): 3067-3067.
DOI:10.1200/jco.2017.35.15_suppl.3067